MDSpire - Takeaway
Feature

Next-Generation Spectacle Lens Aims to Strengthen Myopia Control in Children

New optical design targets stronger signal to slow axial elongation

  • March 25, 2026

  • 5 min

Share

  • 1

    Essilor Stellest 2.0 aims to slow axial elongation.

  • 2

    Incorporates H.A.L.T. MAX technology for enhanced optical performance.

  • 3

    Clinical trials show 1.88x slower eye growth compared to original Stellest.

  • 4

    Features 12 concentric rings of lenslets for improved design.

  • 5

    Targets younger kids for better myopia management.

  • 6

    Myopia prevalence globally is rising, demanding effective interventions.

  • 7

    Offers a non-invasive spectacle solution complementing other treatments.

Original Source(s)

Next-Generation Spectacle Lens Aims to Strengthen Myopia Control in Children

  • March 25, 2026

Related Content

Layer-Specific Corneal Changes in TED

TVST study identifies diffuse stromal thinning in patients with thyroid eye disease

  • March 25, 2026

  • 3 min
Could NPDR Be Treated Orally?

Phase 1b results for danegaptide indicate promising safety profile in patients with non-proliferative diabetic retinopathy and macular edema

  • March 24, 2026

  • 5 min
EYP-1901 in Wet AMD and DME: Insights from the Phase 2 DAVIO 2 and VERONA Trials

An overview of key visual and anatomic findings with EYP-1901 from the DAVIO 2 and VERONA clinical trials, presented at Macula Society 2026

  • March 24, 2026

  • 6 min